Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

Lin JJ, Zhu VW, Yoda S, Yeap BY, Schrock AB, Dagogo-Jack I, Jessop NA, Jiang GY, Le LP, Gowen K, Stephens PJ, Ross JS, Ali SM, Miller VA, Johnson ML, Lovly CM, Hata AN, Gainor JF, Iafrate AJ, Shaw AT, Ou SI
J Clin Oncol. 2018 36 (12): 1199-1206

PMID: 29373100 · PMCID: PMC5903999 · DOI:10.1200/JCO.2017.76.2294

MeSH Terms (18)

Adult Aged Anaplastic Lymphoma Kinase Carcinoma, Non-Small-Cell Lung Crizotinib Drug Resistance, Neoplasm Female Humans Lung Neoplasms Male Middle Aged Mutation Oncogene Proteins, Fusion Prognosis Protein Kinase Inhibitors Retrospective Studies Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: